Clinical trial
Enable® Aortic Sutureless Bioprosthesis Evaluation: A Post-market Release Non-interventional Study
NCT01720342 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Enable® Aortic Sutureless Bioprosthesis Evaluation: A Post-market Release Non-interventional Study
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- April 30, 2018
- Enrollment
- 225 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.